Search

everythinglearnresearchcommunity

for

Search:↓

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Tadalafil and Finasteride may help treat aggressive melanoma.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Peptide drugs now target hard-to-reach proteins more effectively and specifically.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Cadd4 effectively reduces cholesterol levels without side effects.

The p53 protein has complex, sometimes contradictory functions, including tumor suppression and promoting cell survival.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.

Mdm2 is crucial for controlling p53 to maintain healthy cells and prevent tumors.

Asiasari radix extract may be a potential treatment for melanoma because it selectively triggers cell death in melanoma cells by affecting p53 regulation.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

Vinblastine and its metabolites may cause nausea and hair loss by binding to specific receptors and could lead to better chemotherapy drugs with fewer side effects.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Maintaining DNA health in stem cells is key to preventing aging and tissue breakdown.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Antisense oligonucleotides show promise for treating Myotonic Dystrophy type I.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Minoxidil prevents serotonin loss from MDMA by affecting potassium channels and increasing Akt phosphorylation.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

DFMO may help control hair growth and treat cancer.

MXD@CP could be a promising new topical treatment for hair loss.

Myotonic dystrophy should be considered in patients with hair thinning, and genetic counseling is important.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.

Some minoxidil combinations can help differentiate leukemia cells without harming other cells.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

Minoxidil may help treat myelodysplastic syndrome without harming normal blood cell production.

The MXD/24HA salt is more effective for hair growth than raw MXD.

Combining dutasteride mesotherapy with oral minoxidil is more effective for hair loss than using oral minoxidil alone.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.